Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-15

Clinical Trial Update: Efficacy and Safety of Ivabradine on Top of Atenolol in Stable Angina Pectoris [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy and safety of adding ivabradine to atenolol in patients with stable angina pectoris. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atenolol (Atenolol)
  • IVABRADINE

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: Angina Pectoris | Phase 3 | Status: COMPLETED